This announcement is a separate document:
上海君澜律师事务所关于浙江海正药业股份有限公司回购注销2021年限制性股票激励计划部分限制性股票之法律意见书
Legal Opinion of Shanghai Junlan Law Firm on the Repurchase and Cancellation of Some Restricted Shares of the 2021 Restricted Stock Incentive Plan by Zhejiang Haizheng Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.